T
CRL icon

TOBAM’s Charles River Laboratories CRL Stock Holding History

TOBAM’s Portfolio CRL Stock Details CRL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-273
Closed -$54K – 380
2023
Q3 		$54K Sell
273
-215
-44% -$44.1K ﹤0.01% 328
2023
Q2 		$103K Buy
+488
New +$97.1K 0.01% 306
2023
Q1 		– Sell
-447
Closed -$97K – 378
2022
Q4 		$97K Buy
447
+300
+204% +$65.5K 0.01% 302
2022
Q3 		$29K Sell
147
-104
-41% -$22.5K ﹤0.01% 406
2022
Q2 		$54K Hold
251
– – ﹤0.01% 373
2022
Q1 		$71K Buy
+251
New +$77.4K ﹤0.01% 345

Other funds holding CRL

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $34B AUM 6.31% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Allspring Global Investments
Allspring Global Investments Charlotte, North Carolina $59.7B AUM 29.08% 1-Year Est. Return
MG
Meritage Group San Francisco, California $2.65B AUM 6.3% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
AI
Ariel Investments Chicago, Illinois $8.93B AUM 29.58% 1-Year Est. Return